Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 7/20 | 0.46 |
| ▸ | ESR1 | P03372 | 6/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | APLNR | P35414 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | AGL | P35573 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27912 | 1.00 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| SCHEMBL297828 | 1.00 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| SCHEMBL130642 | 1.00 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| SCHEMBL4610 | 1.00 | — | — | |
| SCHEMBL1316560 | 1.00 | ESR2 (0.46) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| Phosphine SCHEMBL23581883 | 0.96 | ESR1 (0.44) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| SCHEMBL8744483 | 0.96 | ESR1 (0.44) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| Methane SCHEMBL11255677 | 0.96 | — | — | |
| Water SCHEMBL9548508 | 0.96 | ESR1 (0.44) | ESR2ESR1CYP3A4CYP2C9APLNR | |
| Hydrochloric Acid SCHEMBL11684727 | 0.96 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113170586-A | Insert molded electronic modules and molded interlocking features using thermally conductive polycarbonate | 科思创有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021132876-A1 | METHOD FOR PRODUCING 1,4-CYCLOHEXANEDIMETHANOL | 한화솔루션 주식회사 | 2021-07-01 | — | — | WO | disclosed |
| WO-2021133138-A1 | METHOD FOR PREPARATION OF 1, 4-CYCLOHEXANEDIMETHANOL | 한화솔루션 주식회사 | 2021-07-01 | — | — | WO | disclosed |
| US-20110245391-A1 | DISPERSIONS COMPRISING FUNCTIONALIZED OXIDIC NANOPARTICLES | BASF SE (DE) | 2011-10-06 | — | — | US | disclosed |
| US-20110230343-A1 | Method for the Manufacture of Microparticles Comprising an Effect Substance | BASF SE (DE) | 2011-09-22 | — | — | US | disclosed |
| US-20110173924-A1 | Energy Absorptive/Moisture Resistive Underlayment Formed Using Recycled Materials and a Hard Flooring System Incorporating the Same | L&P PROPERTY MANAGEMENT COMPANY (US) | 2011-07-21 | — | — | US | disclosed |
| WO-2008144158-A1 | POLYISOCYANURATE FOAM FOR ROOF STRUCTURES | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-11-27 | — | — | WO | disclosed |
| US-20060144012-A1 | Recycled energy absorbing underlayment and moisture barrier for hard flooring system | L&P PROPERTY MANAGEMENT COMPANY (A DELAWARE CORP.) | 2006-07-06 | — | — | US | disclosed |
| EP-0935624-A1 | RIGID POLYURETHANE FOAMS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1999-08-18 | — | — | EP | disclosed |
| WO-1998020058-A1 | RIGID POLYURETHANE FOAMS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1998-05-14 | — | — | WO | disclosed |
| US-5064873-A | Insulation, polyisocyanurate | JIM WALTER RESEARCH CORP. (US) | 1991-11-12 | — | — | US | disclosed |
| EP-0394736-A2 | Polyisocyanurate foam | Jim Walter Research Corp., (US) | 1990-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230343-A1 | Method for the Manufacture of Microparticles Comprising an Effect Substance | APEH, SMPD4, SMPD1 | ESR2 4254/4885ESR1 3956/4885CYP3A4 149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.